Table 1.
Clinicopathological data (N=400)
| Variable | Number of cases (%) |
|---|---|
| Menopausal status | |
| Premenopausal | 28 (7.0%) |
| Perimenopausal | 26 (6.5%) |
| Postmenopausal | 345 (86.3%) |
| Missing data | 1 (0.3%) |
| Age | |
| ≤50 years | 42 (10.5%) |
| >50 years | 358 (89.5%) |
| Obesity | |
| Absent | 197 (49.3%) |
| Present | 202 (50.5%) |
| Missing data | 1 (0.3%) |
| Diabetes | |
| Absent | 300 (75.0%) |
| Present | 100 (25.0%) |
| Hypertension | |
| Absent | 140 (35.0%) |
| Present | 260 (65.0%) |
| Histology | |
| Type I | 307 (76.8%) |
| Type II | 40 (10.0%) |
| Grade 3 | 40 (10.0%) |
| Missing data | 13 (3.3%) |
| Stage (FIGO*) | |
| IA-IB | 277 (69.3%) |
| II | 55 (13.8%) |
| IIIA-IIIC | 47 (11.8%) |
| IVA-IVB | 16 (4.0%) |
| Missing data | 5 (1.3%) |
| Cervical invasion | |
| Absent | 300 (75.0%) |
| Present | 95 (23.8%) |
| Missing data | 5 (1.3%) |
| Myometrial infiltration | |
| ≤1/2 | 198 (49.5%) |
| >1/2 | 197 (49.3%) |
| Missing data | 5 (1.3%) |
| Metastases | |
| Absent | 334 (83.5%) |
| Present | 63 (15.8%) |
| Missing data | 3 (0.8%) |